Literature DB >> 17848139

The epigenetic signature of CFTR expression is co-ordinated via chromatin acetylation through a complex intronic element.

Thankam Paul1, SiDe Li, Sanjeev Khurana, Neal S Leleiko, Martin J Walsh.   

Abstract

The CFTR (cystic fibrosis transmembrane conductance regulator) gene is a tightly regulated and differentially expressed transcript in many mucosal epithelial cell types. It appears that DNA sequence variations alone do not explain CFTR-related gastrointestinal disease patterns and that epigenetic modifiers influence CFTR expression. Our aim was to characterize the native chromatin environment in cultured cells for intestinal CFTR expression by determining the relationship between histone acetylation and occupation of CFTR by multiple transcription factors, through a common regulatory element. We used HDAC (histone deacetylase) inhibition and ChIP (chromatin immunoprecipitation) analyses to define regions associated with acute acetylation of histone at the CFTR locus. We identified a region within the first intron associated with acute acetylation of histone H4 as an epigenetic signature corresponding to an intestine-specific enhancer element for CFTR. DHS (DNase I-hypersensitivity) assays and ChIP were used to specify control elements and occupation by regulatory factors. Quantitative ChIP procedures indicate that HNF1alpha (hepatic nuclear factor 1alpha) and Cdx2 (caudal homeobox protein 2) occupy and regulate through a novel intronic enhancer element of CFTR and that Tcf4 (T-cell factor 4) overlaps the same DNA element. RNAi (RNA interference) of Tcf4 and HNF1alpha decreased intestinal cell CFTR expression, identifying these as positive regulatory factors and CFTR as a target for Wnt signalling. We have linked the acetylation signature of nucleosomal histones to active intestinal CFTR expression and occupation by transcription factors HNF1alpha, Cdx2 and Tcf4 which converge to modify chromatin architecture. These studies suggest the therapeutic potential of histone modification strategies, such as inhibition of HDAC activity, to treat CFTR-associated disease by selectively enhancing CFTR expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17848139      PMCID: PMC2267364          DOI: 10.1042/BJ20070282

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

1.  Molecular biology. The histone modification circus.

Authors:  S L Berger
Journal:  Science       Date:  2001-04-06       Impact factor: 47.728

2.  Cross-species characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene reveals multiple levels of regulation.

Authors:  S Vuillaumier; I Dixmeras; H Messaï; C Lapouméroulie; D Lallemand; J Gekas; F F Chehab; C Perret; J Elion; E Denamur
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

3.  The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation.

Authors:  C Van Lint; S Emiliani; E Verdin
Journal:  Gene Expr       Date:  1996

4.  Expression of the Cdx1 and Cdx2 homeotic genes leads to reduced malignancy in colon cancer-derived cells.

Authors:  G V Mallo; P Soubeyran; J C Lissitzky; F André; C Farnarier; J Marvaldi; J C Dagorn; J L Iovanna
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

5.  Cdx1 promotes differentiation in a rat intestinal epithelial cell line.

Authors:  P Soubeyran; F André; J C Lissitzky; G V Mallo; V Moucadel; M Roccabianca; H Rechreche; J Marvaldi; I Dikic; J C Dagorn; J L Iovanna
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

6.  Hepatic nuclear factor 1-alpha directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets.

Authors:  M Párrizas; M A Maestro; S F Boj; A Paniagua; R Casamitjana; R Gomis; F Rivera; J Ferrer
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

7.  Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4.

Authors:  V Korinek; N Barker; P Moerer; E van Donselaar; G Huls; P J Peters; H Clevers
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

8.  Wnts as essential growth factors for the adult small intestine and colon.

Authors:  Jana Hoffman; Frank Kuhnert; Corrine R Davis; Calvin J Kuo
Journal:  Cell Cycle       Date:  2004-05-15       Impact factor: 4.534

9.  Coordinate regulation of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 genes by hepatocyte nuclear factor 1alpha and the caudal-related homeodomain protein 2.

Authors:  Philip A Gregory; Rikke H Lewinsky; Dione A Gardner-Stephen; Peter I Mackenzie
Journal:  Mol Pharmacol       Date:  2004-04       Impact factor: 4.436

10.  naked cuticle encodes an inducible antagonist of Wnt signalling.

Authors:  W Zeng; K A Wharton; J A Mack; K Wang; M Gadbaw; K Suyama; P S Klein; M P Scott
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

View more
  17 in total

1.  CHD6 regulates the topological arrangement of the CFTR locus.

Authors:  Ana Sancho; SiDe Li; Thankam Paul; Fan Zhang; Francesca Aguilo; Ajay Vashisht; Natarajan Balasubramaniyan; Neal S Leleiko; Frederick J Suchy; James A Wohlschlegel; Weijia Zhang; Martin J Walsh
Journal:  Hum Mol Genet       Date:  2015-01-28       Impact factor: 6.150

2.  Potential Agents for Treating Cystic Fibrosis: Cyclic Tetrapeptides that Restore Trafficking and Activity of ΔF508-CFTR.

Authors:  Darren M Hutt; Christian A Olsen; Chris J Vickers; David Herman; Monica Chalfant; Ana Montero; Luke J Leman; Renner Burkle; Bruce E Maryanoff; William E Balch; M Reza Ghadiri
Journal:  ACS Med Chem Lett       Date:  2011-07-21       Impact factor: 4.345

3.  A balance between activating and repressive histone modifications regulates cystic fibrosis transmembrane conductance regulator (CFTR) expression in vivo.

Authors:  Anne Bergougnoux; Isabelle Rivals; Alessandro Liquori; Caroline Raynal; Jessica Varilh; Milena Magalhães; Marie-José Perez; Nicole Bigi; Marie Des Georges; Raphaël Chiron; Ahmed Saad Squalli-Houssaini; Mireille Claustres; Albertina De Sario
Journal:  Epigenetics       Date:  2014-04-29       Impact factor: 4.528

4.  NF-E2-related factor 2, a key inducer of antioxidant defenses, negatively regulates the CFTR transcription.

Authors:  Céline René; Estelle Lopez; Mireille Claustres; Magali Taulan; Marie-Catherine Romey-Chatelain
Journal:  Cell Mol Life Sci       Date:  2010-03-23       Impact factor: 9.261

5.  Transcriptional networks driving enhancer function in the CFTR gene.

Authors:  Jenny L Kerschner; Ann Harris
Journal:  Biochem J       Date:  2012-09-01       Impact factor: 3.857

Review 6.  Histone deacetylase: a potential therapeutic target for fibrotic disorders.

Authors:  Maoyin Pang; Shougang Zhuang
Journal:  J Pharmacol Exp Ther       Date:  2010-08-18       Impact factor: 4.030

7.  Activation of the unfolded protein response by deltaF508 CFTR.

Authors:  Rafal Bartoszewski; Andras Rab; Asta Jurkuvenaite; Marina Mazur; John Wakefield; James F Collawn; Zsuzsa Bebok
Journal:  Am J Respir Cell Mol Biol       Date:  2008-05-05       Impact factor: 6.914

8.  Interaction of intestinal and pancreatic transcription factors in the regulation of CFTR gene expression.

Authors:  Victoria A McCarthy; Christopher J Ott; Marios Phylactides; Ann Harris
Journal:  Biochim Biophys Acta       Date:  2009-09-24

9.  An insulator element 3' to the CFTR gene binds CTCF and reveals an active chromatin hub in primary cells.

Authors:  Neil P Blackledge; Christopher J Ott; Austin E Gillen; Ann Harris
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

10.  A complex intronic enhancer regulates expression of the CFTR gene by direct interaction with the promoter.

Authors:  Christopher J Ott; Magdalena Suszko; Neil P Blackledge; Jane E Wright; Gregory E Crawford; Ann Harris
Journal:  J Cell Mol Med       Date:  2009-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.